Pay in 4 interest-free payments of $6.68 Learn more
Ships within 48 hours · Estimated delivery Aug 11 - Aug 16
Key takeaways Retatrutide isn't approved yet and isn't expected to launch in the UK until at least mid-2026 In clinical trials, target doses ranged from 0.5mg to 12mg weekly, with the most common being 4mg, 8mg, 9mg and 12mg Different dosing schedules were tested, with most people starting at 2mg and escalating every 4 weeks The 12mg dose produced the most weight loss (up to 28.7% after 68 weeks) Starting at 2mg rather than 4mg helped reduce side effects during escalation First to know Get an email the day retatrutide launches in the UK
Yogurt with live cultures, kefir, sauerkraut, and kimchi are excellent sources of probiotics
Any use of GLP-1 receptor agonists for PCOS should involve shared decision-making between patient and clinician, with clear discussion of the off-label nature of treatment and monitoring requirements
Disordered eating and eating disorders almost always begin with a diet and pursuing intentional weight loss
February 12, 2024
Lower doses of GLP-1 resulted in lower rate of observable side effects based on a sample of 9,528 Microdose GLP-1 Rx Program users
US$ 26.10
US$ 26.35
US$ 22.22
US$ 25.11
US$ 27.67
US$ 22.41
US$ 25.50
US$ 29.17
